Effect of SARS CoV2-Neutralizing Monoclonal Antibody on Hospitalization and Mortality in Long-Term Care Facility Residents

To measure the association between intravenous administration of monoclonal antibody bamlanivimab (LY-CoV555) to long-term care facility (LTCF) residents recently diagnosed with pre-symptomatic, mild-to-moderate COVID-19 and are considered high risk for disease progression with mortality, hospitaliz...

Descripción completa

Detalles Bibliográficos
Autores principales: Murillo, Monika, Lomiguen, Christine, Terrell, Mark, King, Ashley, Lin, James, Ferretti, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JKL International LLC 2022
Materias:
Original Artcile
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9466966/
https://www.ncbi.nlm.nih.gov/pubmed/36186125
http://dx.doi.org/10.14336/AD.2022.0205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9466966/
https://www.ncbi.nlm.nih.gov/pubmed/36186125
http://dx.doi.org/10.14336/AD.2022.0205

Ejemplares similares